By comparing with normal T cells, we identified potential novel markers for SPTCL (e.g., CYTOR, CXCL13, VCAM1, and TIMD4) specifically differentially expressed in the malignant cells. The gene discussed is TIMD4; the disease is subcutaneous panniculitis-like T-cell lymphoma.